Posted in | News | Medical Robotics

Health Robotics Reviews 25-Year History of IV Automation and IV Robotics Sectors

On the 25th anniversary of the first RIVA announcement in Winnipeg [1989], Health Robotics thought appropriate and timely to review the 25-year history of the IV Automation and IV Robotics sectors, major milestones, industry consolidation moves and acquisitions, and the effect of new companies entering the Automation sector and 2nd generation products changing the competitive landscape.

Gaspar DeViedma, Health Robotics' Executive Vice President stated: "It is not unexpected that after Health Robotics reached 500 global installations and 80-90% global market share [with its open IV consumables design for the vast majority of IV Bags, Syringes, etc.], some large industry players such as BD, Fresenius Kabi, Baxter, ICU, entered the sector with at best, partially-automated products to protect revenues of their proprietary IV consumables. In my opinion, pharmacists should exercise a "buyer-beware" attitude in their purchasing decisions and conduct extensive due diligence with "apples to apples" comparisons between proprietary semi-automated IV products and Health Robotics' fully-automated solutions."

Just as an example, Fresenius Kabi [after their 4-year old failed RIVA installation], acquired semi-automated MDS and selectively market it in some countries while of course requiring separate laminar airflow hoods or isolators for its operation: http://www.health-robotics.com/en/competition/ivstation-onco-vs-fresenius-pharmahelp/

In parallel, Loccioni and most of the individuals [management and salespeople] that were responsible for the now-settled Devon Robotics' litigation with hospitals are attempting to sell a copy of the old semi-automated CytoCare, by changing its label to APOTECAchemo, with an "apples and oranges" comparison available at: http://www.health-robotics.com/en/competition/ivstation-onco-vs-loccioni-apoteca/

Health Robotics will continue to add/or update side-by-side competitive analysis comparisons on an ongoing basis in a continuous effort to make buyers beware.

Source: http://www.health-robotics.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.